Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-138454
Filing Date
2025-06-10
Accepted
2025-06-10 16:08:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 d56286d424b3.htm 424B3 392076
2 GRAPHIC g56286g0606090330009.jpg GRAPHIC 3371
3 GRAPHIC g926165dsp1.jpg GRAPHIC 2434
4 GRAPHIC g926165g55d35.jpg GRAPHIC 2920
5 GRAPHIC g926165g93d71.jpg GRAPHIC 2043
6 GRAPHIC g926165g94s53.jpg GRAPHIC 2130
  Complete submission text file 0001193125-25-138454.txt   411759
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 251037145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)